However, a recent study in South African Afrikaners demonstrated a founder effect in which most ARPKD patients are homozygous for a single PKHD1 mutation and yet the clinical phenotypes in this cohort are variable [45]. This evidence concerns the gene PKHD1 and autosomal recessive polycystic kidney disease.